CD8A and tuberculosis: A large TB vaccine trial in South Africa, which investigated correlates of TB disease risk or protection, found an association between CD8 T‐cell activation and HCMV response 8 that was linked to an increased risk of TB disease and shorter time to diagnosis 13.